Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Kinetics of SARS-CoV-2 infection in the human upper and lower respiratory tracts and their relationship with infectiousness
Ruian Ke, Carolin Zitzmann, Ruy M. Ribeiro, et al.
medRxiv (Cold Spring Harbor Laboratory) (2020)
Open Access | Times Cited: 58

Showing 1-25 of 58 citing articles:

The total number and mass of SARS-CoV-2 virions
Ron Sender, Yinon M. Bar-On, Shmuel Gleizer, et al.
Proceedings of the National Academy of Sciences (2021) Vol. 118, Iss. 25
Open Access | Times Cited: 238
Modeling SARS-CoV-2 viral kinetics and association with mortality in hospitalized patients from the French COVID cohort
Nadège Néant, Guillaume Lingas, Quentin Le Hingrat, et al.
Proceedings of the National Academy of Sciences (2021) Vol. 118, Iss. 8
Open Access | Times Cited: 218
Viral dynamics of acute SARS-CoV-2 infection and applications to diagnostic and public health strategies
Stephen M. Kissler, Joseph R. Fauver, Christina Mack, et al.
PLoS Biology (2021) Vol. 19, Iss. 7, pp. e3001333-e3001333
Open Access | Times Cited: 173
A quantitative model used to compare within-host SARS-CoV-2, MERS-CoV, and SARS-CoV dynamics provides insights into the pathogenesis and treatment of SARS-CoV-2
Kwang Su Kim, Keisuke Ejima, Shoya Iwanami, et al.
PLoS Biology (2021) Vol. 19, Iss. 3, pp. e3001128-e3001128
Open Access | Times Cited: 133
Quantifying the relationship between SARS-CoV-2 viral load and infectiousness
Aurélien Marc, Marion Kerioui, François Blanquart, et al.
eLife (2021) Vol. 10
Open Access | Times Cited: 126
Mechanistic Modeling of SARS‐CoV‐2 and Other Infectious Diseases and the Effects of Therapeutics
Alan S. Perelson, Ruian Ke
Clinical Pharmacology & Therapeutics (2021) Vol. 109, Iss. 4, pp. 829-840
Open Access | Times Cited: 94
Identification of a therapeutic interfering particle—A single-dose SARS-CoV-2 antiviral intervention with a high barrier to resistance
Sonali Chaturvedi, Gustavo Vasen, Michael Pablo, et al.
Cell (2021) Vol. 184, Iss. 25, pp. 6022-6036.e18
Open Access | Times Cited: 57
Success of prophylactic antiviral therapy for SARS-CoV-2: Predicted critical efficacies and impact of different drug-specific mechanisms of action
Peter Czuppon, Florence Débarre, António Gonçalves, et al.
PLoS Computational Biology (2021) Vol. 17, Iss. 3, pp. e1008752-e1008752
Open Access | Times Cited: 55
Effect of remdesivir on viral dynamics in COVID-19 hospitalized patients: a modelling analysis of the randomized, controlled, open-label DisCoVeRy trial
Guillaume Lingas, Nadège Néant, Alexandre Gaymard, et al.
Journal of Antimicrobial Chemotherapy (2022) Vol. 77, Iss. 5, pp. 1404-1412
Open Access | Times Cited: 37
Modeling recapitulates the heterogeneous outcomes of SARS-CoV-2 infection and quantifies the differences in the innate immune and CD8 T-cell responses between patients experiencing mild and severe symptoms
Budhaditya Chatterjee, Harshbir Singh Sandhu, Narendra M. Dixit
PLoS Pathogens (2022) Vol. 18, Iss. 6, pp. e1010630-e1010630
Open Access | Times Cited: 29
Innate Immunity Plays a Key Role in Controlling Viral Load in COVID-19: Mechanistic Insights from a Whole-Body Infection Dynamics Model
Prashant Dogra, Javier Ruiz-Ramírez, Kavya Sinha, et al.
ACS Pharmacology & Translational Science (2020) Vol. 4, Iss. 1, pp. 248-265
Open Access | Times Cited: 39
Daily sampling of early SARS-CoV-2 infection reveals substantial heterogeneity in infectiousness
Ruian Ke, Pamela P. Martinez, Rebecca L. Smith, et al.
medRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 34
Quasispecies of SARS-CoV-2 revealed by single nucleotide polymorphisms (SNPs) analysis
Rongsui Gao, Wenhong Zu, Yang Liu, et al.
Virulence (2021) Vol. 12, Iss. 1, pp. 1209-1226
Open Access | Times Cited: 32
A simple model of COVID-19 explains disease severity and the effect of treatments
Steven Sanche, Tyler Cassidy, P.-H. Chu, et al.
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 22
The total number and mass of SARS-CoV-2 virions
Ron Sender, Yinon M. Bar-On, Shmuel Gleizer, et al.
medRxiv (Cold Spring Harbor Laboratory) (2020)
Open Access | Times Cited: 38
Autocrine and paracrine interferon signalling as ‘ring vaccination’ and ‘contact tracing’ strategies to suppress virus infection in a host
G. Michael Lavigne, Hayley Russell, Barbara Sherry, et al.
Proceedings of the Royal Society B Biological Sciences (2021) Vol. 288, Iss. 1945, pp. 20203002-20203002
Open Access | Times Cited: 30
The SARS-CoV-2 pandemic: remaining uncertainties in our understanding of the epidemiology and transmission dynamics of the virus, and challenges to be overcome
Roy M. Anderson, Carolin Vegvari, T. Déirdre Hollingsworth, et al.
Interface Focus (2021) Vol. 11, Iss. 6
Open Access | Times Cited: 29
Optimizing COVID-19 control with asymptomatic surveillance testing in a university environment
Cara E. Brook, Graham R. Northrup, Alexander J. Ehrenberg, et al.
Epidemics (2021) Vol. 37, pp. 100527-100527
Open Access | Times Cited: 28
How time-scale differences in asymptomatic and symptomatic transmission shape SARS-CoV-2 outbreak dynamics
Jeremy D. Harris, Sang Woo Park, Jonathan Dushoff, et al.
Epidemics (2023) Vol. 42, pp. 100664-100664
Open Access | Times Cited: 11
Challenges in modeling the emergence of novel pathogens
Emma E. Glennon, Marjolein Bruijning, Justin Lessler, et al.
Epidemics (2021) Vol. 37, pp. 100516-100516
Open Access | Times Cited: 25
Quantification of the Tradeoff between Test Sensitivity and Test Frequency in a COVID-19 Epidemic—A Multi-Scale Modeling Approach
Jonathan E. Forde, Stanca M. Ciupe
Viruses (2021) Vol. 13, Iss. 3, pp. 457-457
Open Access | Times Cited: 23
Decomposing the sources of SARS-CoV-2 fitness variation in the United States
Lenora Kepler, Marco Hamins-Puértolas, David A. Rasmussen
Virus Evolution (2021) Vol. 7, Iss. 2
Open Access | Times Cited: 23
Spatially distributed infection increases viral load in a computational model of SARS-CoV-2 lung infection
Melanie Moses, Steven Hofmeyr, Judy L. Cannon, et al.
PLoS Computational Biology (2021) Vol. 17, Iss. 12, pp. e1009735-e1009735
Open Access | Times Cited: 23
Modelling the response to vaccine in non-human primates to define SARS-CoV-2 mechanistic correlates of protection
Marie Alexandre, Romain Marlin, Mélanie Prague, et al.
eLife (2022) Vol. 11
Open Access | Times Cited: 14
Making waves: Integrating wastewater surveillance with dynamic modeling to track and predict viral outbreaks
Tin Phan, Samantha Brozak, Bruce Pell, et al.
Water Research (2023) Vol. 243, pp. 120372-120372
Open Access | Times Cited: 8
Page 1 - Next Page

Scroll to top